Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-006313
Filing Date
2017-02-03
Accepted
2017-02-03 08:55:21
Documents
88
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-23340_110q.htm 10-Q 1431868
2 EX-31.1 a16-23340_1ex31d1.htm EX-31.1 9458
3 EX-31.2 a16-23340_1ex31d2.htm EX-31.2 9493
4 EX-32 a16-23340_1ex32.htm EX-32 7496
  Complete submission text file 0001104659-17-006313.txt   8978772

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT lci-20161231.xml EX-101.INS 2191568
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lci-20161231.xsd EX-101.SCH 70136
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lci-20161231_cal.xml EX-101.CAL 102011
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lci-20161231_def.xml EX-101.DEF 253166
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT lci-20161231_lab.xml EX-101.LAB 743883
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lci-20161231_pre.xml EX-101.PRE 491808
Mailing Address 9000 STATE ROAD 9000 STATE ROAD PHLADELPHIA PA 19136
Business Address 9000 STATE RD PHILADELPHIA PA 19136 2153339000
LANNETT CO INC (Filer) CIK: 0000057725 (see all company filings)

EIN.: 230787699 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31298 | Film No.: 17570307
SIC: 2834 Pharmaceutical Preparations